Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5785
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas ; volume:2 ; number:2 ; day:16 ; month:6 ; year:2009 ; pages:83-87 ; date:7.2009
Journal of hematopathology ; 2, Heft 2 (16.6.2009), 83-87, 7.2009
- Creator
-
Balague Ponz, Olga
Ott, German
Hasserjian, Robert P.
Elenitoba-Johnson, Kojo S. J.
Leval, Laurence de
Jong, Daphne de
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12308-009-0038-8
- URN
-
urn:nbn:de:101:1-2021081508573144157024
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Balague Ponz, Olga
- Ott, German
- Hasserjian, Robert P.
- Elenitoba-Johnson, Kojo S. J.
- Leval, Laurence de
- Jong, Daphne de
- SpringerLink (Online service)
Other Objects (12)
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Aggressive B‐cell lymphomas with a primary bone marrow presentation
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
The predictive significance of CD20 expression in B-cell lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Aggressive B‐cell lymphomas with a primary bone marrow presentation
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
The predictive significance of CD20 expression in B-cell lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Aggressive B‐cell lymphomas with a primary bone marrow presentation
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas